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Abstract: Evolutionary hypotheses predict that male fetuses are more vulnerable to poor
maternal conditions (Sex-biased Maternal Investment), but female fetuses are at greater risk
of glucocorticoid-mediated disorders where there is a mismatch between fetal and postnatal
environments (Predictive Adaptive Response). Self-reported prenatal and postnatal depression
and maternal report of child anxious-depressed symptoms at 2.5, 3.5 and 5.0 years were obtained
from an ‘extensive’ sample of first-time mothers (N = 794). Salivary NR3C1 1-F promoter methylation
was assayed at 14 months in an ‘intensive’ subsample (n = 176) and stratified by psychosocial risk.
Generalised structural equation models were fitted and estimated by maximum likelihood to allow
the inclusion of participants from both intensive and extensive samples. Postnatal depression was
associated with NR3C1 methylation and anxious-depressed symptoms in daughters of mothers with
low prenatal depression (prenatal-postnatal depression interaction for methylation, p < 0.001; for child
symptoms, p = 0.011). In girls, NR3C1 methylation mediated the association between maternal
depression and child anxious-depressed symptoms. The effects were greater in girls than boys: the
test of sex differences in the effect of the prenatal-postnatal depression interaction on both outcomes
gave X2 (2) = 5.95 (p = 0.051). This was the first human study to show that epigenetic and early
behavioural outcomes may arise through different mechanisms in males and females.
Keywords: maternal depression; NR3C1 methylation; child anxiety-depression; sex differences;
parental reproductive investment; epidemiological sampling; mediation; longitudinal design
1. Introduction
The ‘fetal origins’ hypothesis was first proposed to account for associations between low birth
weight and obesity, cardiovascular disease, and type II diabetes in middle and old age [1]. According
to this hypothesis, low birth weight reflects evolved adaptive mechanisms that confer advantages
later in life where food is scarce but create risk in the presence of high calorie diets, common in
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industrialised societies. Far from being a mechanism specific to nutrition in humans, adaptations prior
to birth that anticipate later environments are found across species, possibly reflecting a conserved
‘Predictive Adaptive Response’ (PAR) mechanism [2,3]. According to the PAR hypothesis, matched
prenatal and postnatal conditions will be associated with good outcomes, while mismatching creates
risks for poor outcomes. Regarding effects on psychiatric disorders, many studies have reported
that anxiety, depression and behavioural symptoms in children are predicted by prenatal stressors,
maternal depression and anxiety, and by low birth weight [4–9]. We previously reported that the
association between prenatal anxiety and child emotional and behavioural outcomes is only seen
in the presence of low maternal stroking, consistent with animal studies of the protective effects of
postnatal tactile stimulation [8]. In addition, we showed that mismatched prenatal–postnatal maternal
anxiety was associated with elevated child irritability at age 7 years, only in the presence of low
maternal stroking [10], consistent with a mismatch effect creating vulnerability that is modified by
early tactile stimulation.
Fetal adaptations may additionally vary by the sex of the fetus. According to the Trivers–Willard
(T–W) hypothesis, if maternal health during pregnancy predicts later reproductive fitness in the
offspring, then a male predominance of births will be favoured when maternal conditions are good
because healthy males compete successfully for females. By contrast, when maternal conditions are poor,
the sex ratio will be reversed, both to avoid bearing males who compete less successfully for females, but
also because, compared to females, health outcomes for mothers following male births are poorer [11].
Although this hypothesis has been subject to challenges and modifications [12], the central idea that
reproductive strategies associated with poor maternal conditions involve the sacrifice of males and
the protection of females has received substantial support. It is also consistent with well-documented
observations that male fetuses are more vulnerable to threats such as preterm births and are more
likely to suffer neurodevelopmental consequences of fetal insults [13]. This hypothesis appears to
predict better outcomes for females following poor maternal conditions. However, if this protective
effect in females arises from advantages conferred by fetal anticipation of matched environments
(PAR hypothesis), mismatches between maternal conditions during pregnancy and the postnatal
environment create vulnerability. Combining the T–W and PAR hypotheses leads to the prediction
that the effects of prenatal risks operate differently in males and females. In females, vulnerability is
generated by particular combinations of prenatal and postnatal risks, while in males, poor outcomes
arise incrementally from the degree of prenatal risk. In the only human study we are aware of to have
examined the combined effects predicted by the T–W and PAR hypotheses, matched environments
indexed by prenatal and postnatal depression (low–low and high–high) were associated with better
cognitive and motor outcomes over the first year of life than mismatched prenatal and postnatal
depression, and this effect was seen in females only [14]. However, many studies have reported sex
differences in developmental outcomes in relation to prenatal risks without examining for the interplay
with postnatal environments. Sex differences in fetal responses to stress [15], and in later emotional
and behavioural problems following maternal anxiety or depression during pregnancy and low birth
weight [4,7,8,16,17], have been identified.
In animal models, prenatal and postnatal stress cause long-term elevations in hypothalamic
pituitary axis (HPA) reactivity and anxiety-like behaviours. This is mediated via reduced glucocorticoid
receptor (GR) gene NR3C1 expression, particularly in the hippocampus, which impairs HPA axis
feedback mechanisms [18]. The epigenetic process of DNA methylation involves the addition of
methyl groups to CpG dinucleotides in gene regulatory regions that are associated with repressed gene
expression. Animal findings of the epigenetic effects of early life stress have been translated to humans
in a study reporting elevated NR3C1 1-F promoter methylation and reduced NR3C1 expression in
post-mortem hippocampal tissue of people who have committed suicide and who were abused during
childhood when compared to non-abused [19]. Other studies using peripheral DNA from the blood
or saliva of infants and adolescents have shown increased levels of NR3C1 methylation associated
with prenatal and childhood adversities [20–22]. Several clinical studies examining leukocytes have
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reported elevated methylation of the homologous human NR3C1 1-F promoter (homologous to the
rat 1-7 promoter) at a specific CpG (CpG unit 22,23, Figure 1) associated with prenatal maternal
depression [20,23–25] and childhood stress [26]. Studies in humans also find associations between
prenatal anxiety and postnatal depression in mothers, and adolescent depressive symptoms mediated
via HPA axis dysregulation [27,28], consistent with the role of HPA axis dysregulation in adolescent
depression [29]. Higher NR3C1 methylation levels, hypothesised to contribute to reduced NR3C1
expression [19], have been associated with increased salivary cortisol stress responses in infants at
3 months [20] and a flattened cortisol recovery slope following stress in adolescents [30], suggesting
that methylation of NR3C1 may impair negative feedback of the HPA axis.
Figure 1. Scheme of the human NR3C1 gene analyzed by bisulfite pyrosequencing. The 5′- end of the
human NR3C1 gene contains multiple first exons with multiple transcriptional start sites and mRNA
splice variants. The region analyzed by bisulfite pyrosequencing contains 29 CpGs and encompasses
exon 1-F, which is the human homolog of the rat exon 1–7, previously shown to be differentially
methylated [31].
In the first study to examine the interplay between prenatal and postnatal depression in relation
to NR3C1 gene methylation, we showed that the association between postnatal maternal depression
and NR3C1 1-F promoter methylation in children was stronger where mothers had reported lower
depression during pregnancy, in line with the PAR hypothesis [32]. However, we did not examine for
sex differences. Sex differences in glucocorticoid mechanisms associated with prenatal stress have been
shown in animal models. In rats, many effects of prenatal stress on later development are seen only in
females, and these are abolished by adrenalectomy [33]. The effects predicted by a combination of the
T–W and PAR hypotheses have been demonstrated in starlings where mismatched prehatch-posthatch
conditions had a greater effect on corticosterone levels in female than male chicks, but prenatal risk
increased mortality in male chicks [34,35]. In humans, a sex difference in associations between prenatal
depression and NR3C1 1-F promoter methylation has been reported [36], although the interplay with
postnatal depression was not examined.
In this study we examined predictions based on the T–W sex-biased parental investment and
PAR hypotheses. In females, where individual and species vulnerability are reduced by matching
environments but increased by mismatching, the presence of good prenatal conditions followed by
adverse rearing experiences, and vice versa, create vulnerability to child anxiety and depression. Based
on the animal models, we predicted that this effect in females would involve altered HPA axis reactivity
arising from epigenetic modifications of the GR gene. In males, where individuals are sacrificed
for species advantage, the presence of prenatal stress will create vulnerability, unmodified by later
environment quality. The animal models suggest that glucocorticoid mechanisms are implicated in
excess male deaths under unfavourable maternal conditions, but they may not contribute to effects of
prenatal stress on functioning after birth.
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These predictions were tested in a longitudinal study, using measures of prenatal and postnatal
depression, of NR3C1 1-F promoter region methylation at 14 months of age, and anxious depressed
symptoms in children across the preschool period. We predicted that in girls, but not boys, low prenatal
depression followed by high postnatal maternal depression, and high prenatal depression followed
by low postnatal depression would be associated with elevated anxious depressed symptoms and
elevated NR3C1 methylation, which would mediate the association between mismatched maternal
depression and child anxious-depressed symptoms. In boys, we hypothesised that prenatal and
postnatal depression would be independent risks for elevated anxious-depressed symptoms, without
the interaction between them predicted for females.
2. Materials and Methods
2.1. Design
The participants were members of the Wirral Child Health and Development Study, a prospective
epidemiological longitudinal cohort of first-time mothers recruited in pregnancy to study prenatal
and infancy origins of emotional and behavioural disorders. The full cohort of 1233 mothers with live
singleton births had participated in several waves of assessment with a stratified random sub-sample
of 316 identified for an additional, more intensive assessment (intensive sample). Strata were defined
on the basis of low, medium and high psychosocial risk (scores of <=2, 3 or >3 on an inter-partner
psychological abuse scale provided on entry to the study at 20 weeks of pregnancy), with higher
selection probabilities for those at higher risk. Appropriately analysed, the design allowed estimates
of means and coefficients for the whole general population cohort to be derived, even for measures
available only in the intensive sample [37].
Approval for the procedures was obtained from the Cheshire North and West Research Ethics
Committee (UK) (reference no. 05/Q1506/107). The extensive sample was identified from consecutive
first-time mothers who booked for antenatal care at 12 weeks of gestation between 12 February 2007
and 29 October 2008. The booking clinic was administered by the Wirral University Teaching Hospital,
which was the sole provider of universal prenatal care on the Wirral Peninsula. Socioeconomic
conditions on the Wirral range between the deprived inner city and aﬄuent suburbs, but with few
from ethnic minorities. The study was introduced to the women by clinic midwives who asked for
their agreement to be approached by study research midwives when they attended for ultrasound
scanning at 20 weeks of gestation. After complete description of the study to the women, written
informed consent was obtained by the study midwives, who then administered questionnaires and an
interview in the clinic.
2.2. Participants
Of those approached by study midwives, 68.4% gave consent and completed the measures,
yielding an extensive sample of 1233 mothers with surviving singleton babies. The sampling flow chart
has been published previously [36]. The mean age at recruitment of the extensive sample participants
was 26.8 years (s.d. 5.8, range 18–51). Using the UK Index of Multiple Deprivation (IMD) [38] based on
data collected from the UK Census in 2001, 36.6% of the extensive sample reported socioeconomic
profiles found in the most deprived UK quintile, consistent with the high levels of deprivation in some
parts of the Wirral. Forty-eight women (3.9%) described themselves as other than White British.
In addition to assessments of the mothers at 20 weeks of gestation, mothers and infants provided
data at birth and postnatally at 5, 9, and 29 weeks, and at 14.19, s.d. 1.71 months (‘14 months’),
30.86, s.d. 2.31 months (‘2.5 years’), 41.90 s.d. 2.48 months (‘3.5 years’) and 58.64 s.d. 3.74 months
(‘5 years’). Two hundred and sixty-eight mothers and infants came into the lab at 14 months for detailed
observational, interview and physiological measures. This was the first occasion at which saliva for
DNA was collected. Seven parents declined consent for DNA collection, 3 samples were spoilt, and
25 assessments were curtailed before saliva collection because of time constraints. Sufficient DNA for
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methylation analyses was obtained from 181 infants. Maternal reports of child anxious-depressed
symptoms were available on 253 of the intensive sub-cohort at 2.5 years, on 825 of the whole cohort at
3.5 years and on 768 of the whole cohort at 4.5 years.
2.3. Measures
Maternal depression. Maternal symptoms of depression were assessed at 20 weeks gestation and at
every follow up point using the Edinburgh Postnatal Depression Scale (EPDS), which has been used
extensively to assess prenatal and postnatal depression [39].
DNA methylation. Methylation status in the NR3C1 1-F promoter was examined at the
same CpGs (CpG unit 22 and 23, shown in Figure 1) identified in previous studies (25). DNA
collected from Oragene® saliva samples was extracted, bisulphite treated, amplified (Forward,
GACCTGGTCTCTCTGGGG; Reverse, TGCAACCCCGTAGCCCCTTTC) and run on a Sequenom
EpiTYPER system (Sequenom Inc., San Diego, US), providing an average for methylation across the
two CpG units. Data were transformed to the percentage of methylation at CpG units 22 and 23 to
allow for comparison with previous analyses of differential methylation at this locus.
Child anxious-depressed symptoms. Child symptoms were assessed by maternal report at 2.5, 3.5
and 5.0 years using the preschool Child Behavior Checklist (CBCL) [40]. It has 99 items, each scored
0 (not true), 1 (somewhat or sometimes true), and 2 (very true or often true), which are summed to
create seven syndrome scales. Only the anxious/depressed scale was analysed for this report, and as
recommended in the CBCL manual, raw scores were used [41].
Stratification variable and confounders. Partner psychological abuse was assessed using a 20-item
questionnaire covering humiliating, demeaning or threatening utterances in the partner relationship
during pregnancy over the previous year [42]. Maternal age (at this first pregnancy), marital status at
20 weeks of gestation, and socioeconomic status were included as covariates because of their established
associations with adult depression. Socioeconomic status was determined using the revised English
Index of Multiple Deprivation (IMD) [38] based on neighborhood deprivation. All the mothers were
given IMD ranks according to the postcode of the area where they lived and assigned to a quintile
based on the UK distribution of deprivation. The mothers’ years of education at enrolment in the
study were recorded. Information about smoking was obtained at 20 and 32 weeks of gestation and
was included because of published associations with altered DNA methylation [43]. Birth records
provided the sex of the infant, one-minute Apgar score, and birth weight and gestational age, from
which a measure of fetal growth was obtained. Low fetal growth is associated with elevated fetal
glucocorticoid exposure and therefore, might be associated with elevated NR3C1 gene methylation.
Obstetric risk was rated using a weighted severity scale developed by a collaboration of American and
Danish obstetricians and paediatric neurologists [44].
2.4. Statistical Analysis
All analyses were undertaken in Stata 14 (StataCorp, 2015). Generalised structural equation
models (SEM) were fitted using the sem procedure and estimated by maximum likelihood to allow
the inclusion of participants from both intensive and extensive strata. The anxiety-depression scores
at 2.5, 3.5 and 5.0 years and NR3C1 percent methylation at 14 months were highly skewed, so scores
were log-transformed and Winsorized at 2.5 standard deviations to reduce their skew. For further
robustness, we report standard errors and p-values based on the heteroscedastic consistent estimator of
the parameter covariance matrix. The main analyses included the stratification variable and confounds,
except for perinatal confounds as they may lie on a mediational pathway from prenatal depression,
however, the effect of adding those variables was examined. Model estimates and tests allowed for
differential missingness associated with any of the covariates and observed responses included in the
model, accounting for the stratified study design.
The pre-post environment mismatch predictions on both methylation and child symptoms were
examined first by testing for two-way interactions between prenatal and postnatal depression in
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models estimated separately in females and males. We then tested for the sex difference by examining
the three-way, sex by prenatal depression by postnatal depression interactions in a model that included
both genders. The effects of combinations of prenatal and postnatal depression giving rise to these
interaction effects are shown in the figures. The prediction of additive effects of prenatal and postnatal
depression in boys was examined in models without interaction terms.
In the fitted models, methylation was specified as a factor, measured without error by the observed
methylation, a device that implicitly imputes rates of methylation where these have not been observed
in a manner which recognised our uncertainty in these unobserved values. This enabled participants
with partial data that were informative for some parts of the model to be included.
3. Results
Table 1 provides summary statistics for males and females separately for the measures included
in the analysis and shows the sample size at each data collection point. As described in the statistical
analysis section, differences in the available sample for different measures were accounted for by the use
of weighted, maximum likelihood or covariate adjusted estimators. Figure 2 shows the structure of the
SEM model in which maternal history of depression predicts NR3C1 methylation (solid red arrows) and
maternal report of child anxious-depressed symptoms (solid black arrows). These analyses included
the 412 girls and 382 boys on whom there were measures of maternal depression and maternal report
of child anxious-depressed symptoms at a minimum of one follow-up point, as well as all confounders.
Table 1. Summary statistics for outcomes, predictors and variables included as potential confounders
for the modelled sample (I = measure based on intensively assessed sub-sample only).
Girls Boys
N Mean SD N Mean SD
Child anxious-depressed symptoms 2.5 years (I) 125 1.54 1.77 120 1.27 1.61
Child anxious-depressed symptoms 3.5 years 387 1.60 1.64 366 1.59 1.70
Child anxious-depressed symptoms 5 years 372 1.76 1.96 347 1.78 2.01
Child NR3C1 methylation (I) 89 3.42 1.85 87 3.55 1.96
Prenatal EPDS maternal depression scores 412 6.94 4.74 382 7.42 4.54
Mean postnatal EPDS maternal depression scores 412 5.24 3.92 382 5.79 4.35
Stratum low
412
77%
382
75%
Stratum mid 8% 7%
Stratum high 16% 18%
Maternal age < 21 years
412
10%
382
12%
Maternal age 21–30 years 56% 56%
Maternal age > 30 years 34% 32%
No maternal education beyond age 18 412 62% 382 67%
Smoking–none
412
62%
382
64%
Smoking before pregnancy 21% 19%
Smoking during pregnancy 17% 18%
No partner 412 17% 382 19%
Most Deprived Quintile 412 37% 382 36%
Obstetric risk index 412 2.20 1.18 382 2.20 1.19
Birthweight/gestation (gm/wk) 412 83.6 11.9 382 86.5 11.4
1 Minute Apgar score 412 8.95 1.60 382 8.86 1.76
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Figure 2. Structural equation model fitted to NR3C1 1-F promoter methylation at 14 months and Child
Behavior Checklist (CBCL) anxious-depressed scores at ages 2.5, 3.5, and 5 years.
Table 2 shows, for girls and boys separately, the estimated path coefficients from the standardised
prenatal depression, postnatal depression and their interaction (product) of primary interest accounting
for the stratification, attrition and confounders. We first tested the prediction that there would be
an interaction between prenatal and postnatal depression in girls but not in boys. In girls, there
was a significant effect of the interaction between prenatal and postnatal depression on both child
anxiety-depression (p = 0.011) and NR3C1 1-F promoter methylation (p < 0.001). For boys, by contrast,
anxious-depressed symptoms were not predicted by the prenatal and postnatal depression interaction
term (p = 0.920), and the effect on NR3C1 methylation was smaller than for girls, though still significant
(p = 0.003). Adding the three additional potential confounders that were assessed after the prenatal
exposure (obstetric risk index, 1-min Apgar score and birthweight/gestational age) made no material
difference to these associations. Fitting this model to boys and girls together but allowing the effects of
prenatal and postnatal depression exposure on the two correlated outcomes to differ by sex (in addition
to a gender main effect), a Wald test of the sex differences in the effect of the prenatal-postnatal
depression interaction on both outcomes (a difference of 0.20 for anxiety-depression and 0.18 for
methylation) gave X2(2) of 5.95 (p = 0.051), with the two individual interactions contributing equally
(anxiety-depression p = 0.088, methylation p = 0.069).
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Table 2. Summary of SEM analyses predicting NR3C1 1-F promoter methylation and child
anxious-depressed symptoms.
|
Female (n = 412)
Standardized Coefficient 95%
Confidence Interval [p-value]
Male (n = 382)
Standardized Coefficient 95%
Confidence Interval [p-value]
Effects on child anxious-depressed symptoms
Prenatal maternal depression −0.06 −0.23, 0.11 0.16 −0.00, 0.33
Postnatal maternal depression 0.21 0.05, 0.38 0.17 0.03, 0.31
Prenatal-postnatal interaction −0.19[p = 0.011] 0.34, −0.05
0.01
[p = 0.920] −0.11, 0.12
Effects on child NR3C1 1-F promoter methylation
Prenatal maternal depression −0.02 −0.28, 0.24 −0.11 −0.34, 0.12
Postnatal maternal depression 0.45 0.16, 0.75 0.38 0.11, 0.65
Prenatal-postnatal interaction −0.39[p = 0.00001] −0.56, −0.21
−0.21
[p = 0.003] −0.32, −0.08
Child anxious-depressed symptoms factor loadings
2.5 years 0.81 0.72
3.5 years 0.80 0.67
5 years 0.57 0.81
Model fit
RMSEA = 0.05 (95% C.I. 0.03–0.07)
CFI = 0.90
RMSEA = 0.01 (95% C.I. 0.01–0.04).
CFI = 1.00
The Table 2 shows standardized factor loadings of child CBCL anxious-depressed symptoms at
ages 2.5, 3.5 and 5 years, and the main effects and effects of the interaction of prenatal and postnatal
depression in the prediction of the anxious-depressed factor and the NR3C1 1-F promoter methylation
(effects of stratification factors and confounders not shown). Anxious-depressed symptoms and
methylation were analysed together as correlated outcomes in an SEM. Coefficients for the effects of
confounders and stratification factors are not shown (stratum, maternal age, maternal smoking, maternal
education, no partner, neighbourhood deprivation). The models reported used robust standard errors
to guard against inferential errors due to non-normality. In order to provide conventional model fit
statistics, the models were run without robust standard errors and the statistics from this are reported
in the final row of the Table 2.
We then tested the prediction that there would be independent and additive effects of prenatal
and postnatal depression in boys by estimating the model (not shown in the Table) for boys without the
interaction term. This showed a significant effect on child anxiety-depression of postnatal depression
(standardised coefficient 0.17, CI 0.04 to 0.30, p = 0.011) and an effect of similar magnitude, of prenatal
depression which was non-significant, (0.15, CI −0.02 to 0.33, p = 0.080). Independent effects on
methylation were not seen (prenatal 0.05, CI −0.17 to 0.27, p = 0.640; postnatal 0.13, CI −0.09 to 0.36,
p = 0.241).
Figure 3 displays how the interactions between prenatal and postnatal depression in the prediction
of anxious-depressed symptoms differed between girls and boys. It can be seen that in girls, at a low
level of prenatal depression (1 standard deviation below the mean), increasing postnatal depression
was strongly associated with increasing child anxious-depressed symptoms, while at a high level, there
was no association. With prenatal depression at the mean, the association was intermediate between
the low and high prenatal levels. In boys, by contrast, as evidenced in parallel regression lines, there
was no interplay between prenatal and postnatal maternal depression.
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Figure 3. Regression lines for the interaction between pre- and post-natal depression and child
anxious-depressed symptoms, showing the effect of postnatal depression at the mean and one standard
deviation on either side of the mean.
As shown in Figure 4, the effects of prenatal-postnatal mismatch on methylation were again strongly
evident in girls, with the greatest association between postnatal depression and methylation in the presence
of low prenatal depression, and progressively weaker associations at higher levels of prenatal depression.
The progressive effect of prenatal depression was also evident in boys but was less strong.
Figure 4. Regression lines for the interaction between pre- and post-natal depression and child NRC31
1-F promoter methylation, showing the effect of postnatal depression at the mean and one standard
deviation either side of the mean. The figure also shows a scatterplot of the association.
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In girls, replacing the correlation between the methylation and anxiety-depression factors by a
causal effect, higher NR3C1 methylation at 14 months, was associated with higher anxiety-depressed
symptoms (standardised coefficient 0.36 CI 0.05 to 0.67, p = 0.025), illustrated in the left-hand panel of
Figure 5. The residual direct effect of the prenatal-postnatal interaction on child anxiety-depression
symptoms was substantially reduced, from −0.19 (shown in Table 2) to −0.06 (CI −0.26 to 0.15),
becoming wholly nonsignificant (p = 0.600). For boys there was no evidence of an effect of methylation
on symptoms (standardised coefficient −0.03, CI −0.31 to 0.24, p = 0.820).
Figure 5. Regression line (and 95% CI) for the association between NRC31 1-F promoter methylation
and child anxiety-depression symptoms in girls and boys. The figure also shows a scatterplot of
the association.
4. Discussion
Many, although not all, of our predictions based on the evolutionary T–W and PAR hypotheses
for sex-biased parental investment and fetal programming were supported in this longitudinal study,
from 20 weeks of pregnancy and over the first 5 years of children’s lives. Mismatching between
prenatal and postnatal maternal depression was associated with greater anxious-depressed symptoms
and NR3C1 methylation in girls. Both effects were most evident in girls exposed to high levels of
postnatal depression. Their symptoms and NR3C1 methylation levels were higher when their mothers
had reported low levels of depression during pregnancy, in line with the idea that they had not
been prepared by the fetal environment for postnatal exposure to maternal depression. In girls only,
elevated NR3C1 methylation was associated with higher anxious-depressed symptoms and mediated
the association between maternal depression and child symptoms. In boys, there was no evidence of
effects of prenatal-postnatal depression mismatch on anxious-depressed symptoms. However, and
contrary to our prediction, the prenatal-postnatal mismatch effect on NR3C1 methylation was seen in
boys as well as in girls, although the size of the effect was smaller.
The strengths of the investigation include a prospective study with a general population sample,
accounting for a number of plausible confounds and factors associated with attrition. Moreover, by
using SEM to create a latent variable from measurement at 3 time points over 2.5 years, we reduced the
risks arising from multiple testing for each time point and we were able to examine the predictions
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in relation to persistently elevated symptoms likely to confer risk for an elevated trajectory for
anxious-depressed symptoms over childhood [45]. The method adopted for missing methylation data
exploited the properties of maximum likelihood for accounting for data assumed missing at random.
Most missingness was by design because of the systematic stratification of the intensive sample, thus
meeting this assumption, and the inclusion of multiple covariates allowed us account for unplanned
attrition. It is nevertheless possible that not all the necessary confounds to deal with non-random
missingness were identified.
There were four principal limitations in relation to the measurement of NR3C1 methylation.
First, peripheral cell samples from both blood and saliva are heterogeneous, which may account for
some of the variability in methylation. This can introduce a confound whereby other variables are
associated with cellular heterogeneity [46]. Second, while studies combining peripheral cell and CNS
post-mortem estimations have suggested that they are often substantially correlated [47], it cannot be
assumed that DNA methylation in peripheral tissues reflects methylation in relevant CNS regions.
This is particularly a concern because of substantial variations in epigenetic effects across brain regions
and cell types. Specifically, it cannot be assumed that variations in the NR3C1 1-F promoter in saliva
reflect variations in glucocorticoid receptor synthesis in the hippocampal regions involved in HPA
axis regulation. Third, DNA methylation is one of a number of epigenetic processes that regulate
gene expression, and does not provide a direct measure of that expression. ‘Mediation’ in this report,
as in the field more widely [48], refers to statistical findings consistent with, but not direct evidence
of, epigenetic mediation. Fourth, there are many combinations of CpG sites, even on a relatively
circumscribed region such as the NR3C1 1-F promoter that could be examined, leading to the risk of
multiple analyses and ‘significant’ findings occurring by chance. Fifth, although we accounted for
several plausible confounds, environmental variables other than those included in analyses may better
account for the findings.
No one study can establish the validity of estimates of peripheral cell methylation as indices of
CNS methylation, however, a finding of the same pattern of associations for peripheral cell methylation
and for behaviours that undoubtedly reflect CNS function, and for mediation of the association between
maternal depression and symptoms by NR3C1 methylation is relevant to the issue. As is evident from
the SEM models, and as seen in Figures 3 and 4, there were striking similarities between the patterns of
associations involving interactions between prenatal and postnatal depression and sex differences, not
only for child anxious-depressed symptom but also for NR3C1 methylation. Furthermore, in this study,
we reduced risks arising from multiple analyses of many potential methylation sites by examining
only one site that had been identified from a meta-analysis of previous studies [24].
5. Conclusions
Our findings are important in five major ways. First, they provide pointers to study designs that
could be introduced into animal models where mechanisms could be examined using experimentally
controlled risks. These would, for example, examine the interplay between prenatal and postnatal risks
in relation to the role of the placenta in regulating the passage of maternal glucocorticoids to the foetus,
which, in turn, can be controlled by further epigenetic modifications of specific placental genes [47].
Second, they illustrate how evolutionary hypotheses regarding parental investment in offspring can
be used to generate novel, and in some ways surprising predictions regarding parenting and early
development in humans [48]. Third, testing in this way can generate further productive questions.
In this study, while there was good evidence for mismatch effects in females on NR3C1 methylation
and child symptoms and for a sex difference in relation to child symptoms, the prenatal-postnatal
depression mismatch was also associated with NR3C1 methylation in males, which was contrary to the
predictions. Further study is needed into the conditions under which fetal programming effects are
seen in males as well as females, and under what conditions there are sex differences in the behavioural
implications of NR3C1 methylation. Fourth, these results show that even though human development
is subject to many complex social and psychological influences, biological mechanisms conserved
Cells 2019, 8, 943 12 of 14
across many non-human species can be highly influential. Fifth, they suggest that some prenatal effects
on epigenetic and behavioural outcomes in early childhood differ radically in males and females, and so
further study of sex-specific mechanisms is needed. This will have implications for our understanding
of the biology of psychiatric disorders arising in childhood.
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